Evolving phase I oncology trials in the precision medicine era: design, outcomes, and geographic access.

Katsuya Y, Koyama T, Sato J, Okada M, Yamamoto N

Open source

DOI
10.1016/j.esmorw.2026.100692
Published
2026 Mar
Container
ESMO real world data and digital oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.esmorw.2026.100692,
  title = {Evolving phase I oncology trials in the precision medicine era: design, outcomes, and geographic access.},
  author = {Katsuya Y and Koyama T and Sato J and Okada M and Yamamoto N},
  year = {2026},
  journal = {ESMO real world data and digital oncology},
  doi = {10.1016/j.esmorw.2026.100692},
  url = {https://doi.org/10.1016/j.esmorw.2026.100692}
}

RIS

TY  - JOUR
TI  - Evolving phase I oncology trials in the precision medicine era: design, outcomes, and geographic access.
AU  - Katsuya Y
AU  - Koyama T
AU  - Sato J
AU  - Okada M
AU  - Yamamoto N
PY  - 2026
JO  - ESMO real world data and digital oncology
DO  - 10.1016/j.esmorw.2026.100692
UR  - https://doi.org/10.1016/j.esmorw.2026.100692
ER  - 

APA

Y, K., T, K., J, S., M, O., & N, Y. (2026). Evolving phase I oncology trials in the precision medicine era: design, outcomes, and geographic access.. ESMO real world data and digital oncology. https://doi.org/10.1016/j.esmorw.2026.100692

Source records